Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Final Report on Clinical Outcomes and Tumor Recurrence Patterns of a Pilot Study Assessing Efficacy of Belinostat (PXD-101) with Chemoradiation for Newly Diagnosed Glioblastoma.
Xu K, Ramesh K, Huang V, Gurbani SS, Cordova JS, Schreibmann E, Weinberg BD, Sengupta S, Voloschin AD, Holdhoff M, Barker PB, Kleinberg LR, Olson JJ, Shu HG, Shim H. Xu K, et al. Among authors: kleinberg lr. Tomography. 2022 Mar 3;8(2):688-700. doi: 10.3390/tomography8020057. Tomography. 2022. PMID: 35314634 Free PMC article. Clinical Trial.
A multi-institutional pilot clinical trial of spectroscopic MRI-guided radiation dose escalation for newly diagnosed glioblastoma.
Ramesh K, Mellon EA, Gurbani SS, Weinberg BD, Schreibmann E, Sheriff SA, Goryawala M, de le Fuente M, Eaton BR, Zhong J, Voloschin AD, Sengupta S, Dunbar EM, Holdhoff M, Barker PB, Maudsley AA, Kleinberg LR, Shim H, Shu HG. Ramesh K, et al. Among authors: kleinberg lr. Neurooncol Adv. 2022 Jan 27;4(1):vdac006. doi: 10.1093/noajnl/vdac006. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 35382436 Free PMC article.
A Novel Approach to Determining Tumor Progression Using a Three-Site Pilot Clinical Trial of Spectroscopic MRI-Guided Radiation Dose Escalation in Glioblastoma.
Ramesh KK, Huang V, Rosenthal J, Mellon EA, Goryawala M, Barker PB, Gurbani SS, Trivedi AG, Giuffrida AS, Schreibmann E, Han H, de le Fuente M, Dunbar EM, Holdhoff M, Kleinberg LR, Shu HG, Shim H, Weinberg BD. Ramesh KK, et al. Among authors: kleinberg lr. Tomography. 2023 Feb 6;9(1):362-374. doi: 10.3390/tomography9010029. Tomography. 2023. PMID: 36828381 Free PMC article. Clinical Trial.
Applying a Radiation Therapy Volume Analysis Pipeline to Determine the Utility of Spectroscopic MRI-Guided Adaptive Radiation Therapy for Glioblastoma.
Trivedi AG, Kim SH, Ramesh KK, Giuffrida AS, Weinberg BD, Mellon EA, Kleinberg LR, Barker PB, Han H, Shu HG, Shim H, Schreibmann E. Trivedi AG, et al. Among authors: kleinberg lr. Tomography. 2023 May 21;9(3):1052-1061. doi: 10.3390/tomography9030086. Tomography. 2023. PMID: 37218946 Free PMC article. Clinical Trial.
Widely metastatic IDH1-mutant glioblastoma with oligodendroglial features and atypical molecular findings: a case report and review of current challenges in molecular diagnostics.
Romo CG, Palsgrove DN, Sivakumar A, Elledge CR, Kleinberg LR, Chaichana KL, Gocke CD, Rodriguez FJ, Holdhoff M. Romo CG, et al. Among authors: kleinberg lr. Diagn Pathol. 2019 Feb 9;14(1):16. doi: 10.1186/s13000-019-0793-5. Diagn Pathol. 2019. PMID: 30738431 Free PMC article. Review.
170 results